Vascular Biogenics Ltd.’s Raising Found

Horn & Co advised Vascular Biogenics Ltd on the deal.

Vascular Biogenics Ltd. raised an additional $8.1 million, completing an aggregate $18.1 million raise.

Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.

The Horn & Co team was led by Yuval Horn (Picture), Keren Kanir and Shimrit Roznek.

Involved fees earner: Yuval Horn – Horn & Co. Law; Keren Kanir – Horn & Co. Law; Shimrit Roznek – Horn & Co. Law;

Law Firms: Horn & Co. Law;

Clients: Vascular Biogenics Ltd.;

Author: Michael Patrini.